Vilya Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
46
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$71M
- Investors
-
9
Vilya General Information
Description
Developer of a biotechnology platform designed to create medicines that precisely target disease biology. The company's platform builds molecular structures that range in size and antibodies, with critical drug-like properties, including the ability to move through biological membranes and to disrupt protein interactions, enabling doctors to effectively treat patients.
Contact Information
Website
www.vilya.aiCorporate Office
- 188 East Blaine Street
- Suite 124
- Seattle, WA 98102
- United States
Corporate Office
- 188 East Blaine Street
- Suite 124
- Seattle, WA 98102
- United States
Vilya Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 04-Jun-2024 | $71M | Completed | Generating Revenue | ||
| 2. Seed Round | Completed | Generating Revenue | ||||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Vilya Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Seed | 927,161 | $0.000100 | $3 | $3 | 1x | $3 | 2.9% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Vilya Comparisons
Industry
Financing
Details
Vilya Competitors (41)
One of Vilya’s 41 competitors is Octant, a Venture Capital-Backed company based in Emeryville, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Octant | Venture Capital-Backed | Emeryville, CA | ||||
| Genevant | Corporate Backed or Acquired | Vancouver, Canada | ||||
| etherna | Formerly VC-backed | Niel, Belgium | ||||
| Atalanta Therapeutics | Venture Capital-Backed | Boston, MA | ||||
| Accent Therapeutics | Venture Capital-Backed | Lexington, MA |
Vilya Signals
Vilya Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Altitude Life Science Ventures | Venture Capital | Minority | ||
| ARCH Venture Partners | Venture Capital | Minority | ||
| Lifeforce Capital | Venture Capital | Minority | ||
| Madrona Venture Group | Venture Capital | Minority | ||
| Menlo Ventures | Venture Capital | Minority |
Vilya FAQs
-
When was Vilya founded?
Vilya was founded in 2022.
-
Where is Vilya headquartered?
Vilya is headquartered in Seattle, WA.
-
What is the size of Vilya?
Vilya has 46 total employees.
-
What industry is Vilya in?
Vilya’s primary industry is Drug Discovery.
-
Is Vilya a private or public company?
Vilya is a Private company.
-
What is the current valuation of Vilya?
The current valuation of Vilya is .
-
What is Vilya’s current revenue?
The current revenue for Vilya is .
-
How much funding has Vilya raised over time?
Vilya has raised $73.8M.
-
Who are Vilya’s investors?
Altitude Life Science Ventures, ARCH Venture Partners, Lifeforce Capital, Madrona Venture Group, and Menlo Ventures are 5 of 9 investors who have invested in Vilya.
-
Who are Vilya’s competitors?
Octant, Genevant, etherna, Atalanta Therapeutics, and Accent Therapeutics are some of the 41 competitors of Vilya.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process